PortalPublikationenValidation of a patient interview for assessing reasons for ...

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.

Standard

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation. / Matza, Louis S; Phillips, Glenn A; Revicki, Dennis A; Ascher-Svanum, Haya; Malley, Karen G; Palsgrove, Andrew C; Faries, Douglas E; Stauffer, Virginia; Kinon, Bruce J; Awad, A George; Keefe, Richard Se; Naber, Dieter.

in: PATIENT PREFER ADHER, Jahrgang 6, 2012, S. 521-532.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Matza, LS, Phillips, GA, Revicki, DA, Ascher-Svanum, H, Malley, KG, Palsgrove, AC, Faries, DE, Stauffer, V, Kinon, BJ, Awad, AG, Keefe, RS & Naber, D 2012, 'Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.', PATIENT PREFER ADHER, Jg. 6, S. 521-532. https://doi.org/10.2147/PPA.S25635

APA

Matza, L. S., Phillips, G. A., Revicki, D. A., Ascher-Svanum, H., Malley, K. G., Palsgrove, A. C., Faries, D. E., Stauffer, V., Kinon, B. J., Awad, A. G., Keefe, R. S., & Naber, D. (2012). Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation. PATIENT PREFER ADHER, 6, 521-532. https://doi.org/10.2147/PPA.S25635

Vancouver

Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC et al. Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation. PATIENT PREFER ADHER. 2012;6:521-532. https://doi.org/10.2147/PPA.S25635

Bibtex

@article{a9f4296c98674431ba13f622a66f73d1,
title = "Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.",
abstract = "The Reasons for Antipsychotic Discontinuation Interview (RAD-I) was developed to assess patients' perceptions of reasons for discontinuing or continuing an antipsychotic. The current study examined reliability and validity of domain scores representing three factors contributing to these treatment decisions: treatment benefits, adverse events, and distal reasons other than direct effects of the medication.",
author = "Matza, {Louis S} and Phillips, {Glenn A} and Revicki, {Dennis A} and Haya Ascher-Svanum and Malley, {Karen G} and Palsgrove, {Andrew C} and Faries, {Douglas E} and Virginia Stauffer and Kinon, {Bruce J} and Awad, {A George} and Keefe, {Richard Se} and Dieter Naber",
year = "2012",
doi = "10.2147/PPA.S25635",
language = "English",
volume = "6",
pages = "521--532",
journal = "PATIENT PREFER ADHER",
issn = "1177-889X",
publisher = "DOVE MEDICAL PRESS LTD",

}

RIS

TY - JOUR

T1 - Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.

AU - Matza, Louis S

AU - Phillips, Glenn A

AU - Revicki, Dennis A

AU - Ascher-Svanum, Haya

AU - Malley, Karen G

AU - Palsgrove, Andrew C

AU - Faries, Douglas E

AU - Stauffer, Virginia

AU - Kinon, Bruce J

AU - Awad, A George

AU - Keefe, Richard Se

AU - Naber, Dieter

PY - 2012

Y1 - 2012

N2 - The Reasons for Antipsychotic Discontinuation Interview (RAD-I) was developed to assess patients' perceptions of reasons for discontinuing or continuing an antipsychotic. The current study examined reliability and validity of domain scores representing three factors contributing to these treatment decisions: treatment benefits, adverse events, and distal reasons other than direct effects of the medication.

AB - The Reasons for Antipsychotic Discontinuation Interview (RAD-I) was developed to assess patients' perceptions of reasons for discontinuing or continuing an antipsychotic. The current study examined reliability and validity of domain scores representing three factors contributing to these treatment decisions: treatment benefits, adverse events, and distal reasons other than direct effects of the medication.

U2 - 10.2147/PPA.S25635

DO - 10.2147/PPA.S25635

M3 - SCORING: Journal article

VL - 6

SP - 521

EP - 532

JO - PATIENT PREFER ADHER

JF - PATIENT PREFER ADHER

SN - 1177-889X

ER -